202 related articles for article (PubMed ID: 30625400)
1. Statin Use After Diagnosis of Hepatocellular Carcinoma Is Associated With Decreased Mortality.
Thrift AP; Natarajan Y; Liu Y; El-Serag HB
Clin Gastroenterol Hepatol; 2019 Sep; 17(10):2117-2125.e3. PubMed ID: 30625400
[TBL] [Abstract][Full Text] [Related]
2. The Association Between Statin Use After Diagnosis and Mortality Risk in Patients With Esophageal Cancer: A Retrospective Cohort Study of United States Veterans.
Nguyen T; Khan A; Liu Y; El-Serag HB; Thrift AP
Am J Gastroenterol; 2018 Sep; 113(9):1310. PubMed ID: 29946180
[TBL] [Abstract][Full Text] [Related]
3. Use of Acid-Suppressant Medications After Diagnosis Increases Mortality in a Subset of Gastrointestinal Cancer Patients.
Ayyagari S; Tan MC; Liu Y; El-Serag HB; Thrift AP
Dig Dis Sci; 2020 Sep; 65(9):2691-2699. PubMed ID: 31802383
[TBL] [Abstract][Full Text] [Related]
4. Postdiagnosis Statin Use and Mortality in Danish Patients With Prostate Cancer.
Larsen SB; Dehlendorff C; Skriver C; Dalton SO; Jespersen CG; Borre M; Brasso K; Nørgaard M; Johansen C; Sørensen HT; Hallas J; Friis S
J Clin Oncol; 2017 Oct; 35(29):3290-3297. PubMed ID: 28806117
[TBL] [Abstract][Full Text] [Related]
5. Lipophilic Statins and Risk for Hepatocellular Carcinoma and Death in Patients With Chronic Viral Hepatitis: Results From a Nationwide Swedish Population.
Simon TG; Duberg AS; Aleman S; Hagstrom H; Nguyen LH; Khalili H; Chung RT; Ludvigsson JF
Ann Intern Med; 2019 Sep; 171(5):318-327. PubMed ID: 31426090
[TBL] [Abstract][Full Text] [Related]
6. Statin use is associated with better post-operative prognosis among patients with hepatitis B virus-related hepatocellular carcinoma.
Yun B; Ahn SH; Oh J; Yoon JH; Kim BK
Eur J Clin Invest; 2023 Apr; 53(4):e13936. PubMed ID: 36504405
[TBL] [Abstract][Full Text] [Related]
7. Statin use and mortality among endometrial cancer patients: a Danish nationwide cohort study.
Sperling CD; Verdoodt F; Kjaer Hansen M; Dehlendorff C; Friis S; Kjaer SK
Int J Cancer; 2018 Dec; 143(11):2668-2676. PubMed ID: 29923185
[TBL] [Abstract][Full Text] [Related]
8. Statin and the risk of hepatocellular carcinoma and death in a hospital-based hepatitis B-infected population: A propensity score landmark analysis.
Hsiang JC; Wong GL; Tse YK; Wong VW; Yip TC; Chan HL
J Hepatol; 2015 Nov; 63(5):1190-7. PubMed ID: 26208777
[TBL] [Abstract][Full Text] [Related]
9. Anticancer Effect of Statins in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma.
Lee HL; Lee SW; Jang JW; Bae SH; Choi JY; Yoon SK; Choi HJ; Na GH; You YK; Park IY; Kim DG
Liver Transpl; 2022 Mar; 28(3):397-406. PubMed ID: 34374192
[TBL] [Abstract][Full Text] [Related]
10. Statin-Based Palliative Therapy for Hepatocellular Carcinoma.
Shao JY; Lee FP; Chang CL; Wu SY
Medicine (Baltimore); 2015 Oct; 94(42):e1801. PubMed ID: 26496314
[TBL] [Abstract][Full Text] [Related]
11. Association of Statin Use With Risk of Liver Disease, Hepatocellular Carcinoma, and Liver-Related Mortality.
Vell MS; Loomba R; Krishnan A; Wangensteen KJ; Trebicka J; Creasy KT; Trautwein C; Scorletti E; Seeling KS; Hehl L; Rendel MD; Zandvakili I; Li T; Chen J; Vujkovic M; Alqahtani S; Rader DJ; Schneider KM; Schneider CV
JAMA Netw Open; 2023 Jun; 6(6):e2320222. PubMed ID: 37358849
[TBL] [Abstract][Full Text] [Related]
12. Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study.
Kim G; Jang SY; Nam CM; Kang ES
J Hepatol; 2018 Mar; 68(3):476-484. PubMed ID: 29107150
[TBL] [Abstract][Full Text] [Related]
13. Statin Use and Survival with Early-Stage Hepatocellular Carcinoma.
Jeon CY; Goodman MT; Cook-Wiens G; Sundaram V
Cancer Epidemiol Biomarkers Prev; 2016 Apr; 25(4):686-92. PubMed ID: 26908429
[TBL] [Abstract][Full Text] [Related]
14. Impact of statin use on the prognosis of patients with hepatocellular carcinoma undergoing liver resection: a subgroup analysis of patients without chronic hepatitis viral infection.
Nishio T; Taura K; Nakamura N; Seo S; Yasuchika K; Kaido T; Okajima H; Hatano E; Uemoto S
Surgery; 2018 Feb; 163(2):264-269. PubMed ID: 29167018
[TBL] [Abstract][Full Text] [Related]
15. Effect of statins on the recurrence of hepatocellular carcinoma after liver transplantation: An illusion revealed by exposure density sampling.
Kim DG; Yim SH; Min EK; Choi MC; Kim MS; Joo DJ; Lee JG
Liver Int; 2023 Sep; 43(9):2017-2025. PubMed ID: 37365992
[TBL] [Abstract][Full Text] [Related]
16. Statin use is associated with a reduced risk of hepatocellular carcinoma recurrence after initial liver resection.
Kawaguchi Y; Sakamoto Y; Ito D; Ito K; Arita J; Akamatsu N; Kaneko J; Hasegawa K; Moriya K; Kokudo N
Biosci Trends; 2017 Nov; 11(5):574-580. PubMed ID: 29081488
[TBL] [Abstract][Full Text] [Related]
17. Effect of statin on hepatocellular carcinoma in patients with type 2 diabetes: A nationwide nested case-control study.
Kim G; Jang SY; Han E; Lee YH; Park SY; Nam CM; Kang ES
Int J Cancer; 2017 Feb; 140(4):798-806. PubMed ID: 27861855
[TBL] [Abstract][Full Text] [Related]
18. Statins are associated with a reduced risk of hepatocellular carcinoma in a large cohort of patients with diabetes.
El-Serag HB; Johnson ML; Hachem C; Morgana RO
Gastroenterology; 2009 May; 136(5):1601-8. PubMed ID: 19208359
[TBL] [Abstract][Full Text] [Related]
19. Independent and Joint Use of Statins and Metformin by Elderly Patients With Diabetes and Overall Survival Following HCC Diagnosis.
Antwi SO; Li Z; Mody K; Roberts LR; Patel T
J Clin Gastroenterol; 2020; 54(5):468-476. PubMed ID: 32271517
[TBL] [Abstract][Full Text] [Related]
20. Statin use and the prognosis of patients with hepatocellular carcinoma: a meta-analysis.
Li X; Liu L; Hu Y
Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32162652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]